Sectors & IndustriesHealthcare

Best Healthcare Stocks to Buy Now (2025)

Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

Embecta (NASDAQ:EMBC) is the #1 top healthcare stock out of 1098 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: C.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 35, which is 10 points higher than the healthcare sector average of 25. It passed 12 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock return 1.99% over the past year, overperforming other healthcare stocks by 30 percentage points.

Embecta has an average 1 year price target of $18.50, an upside of 38.58% from Embecta's current stock price of $13.35.

Embecta stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Embecta, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #2 top healthcare stock out of 1098 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: B, and AI: C.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 37, which is 12 points higher than the healthcare sector average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 12.59% over the past year, overperforming other healthcare stocks by 41 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $14.00, an upside of 43.59% from Amneal Pharmaceuticals's current stock price of $9.75.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Aveanna Healthcare Holdings (NASDAQ:AVAH) is the #3 top healthcare stock out of 1098 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aveanna Healthcare Holdings (NASDAQ:AVAH) is: Value: C, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: C, and AI: C.

Aveanna Healthcare Holdings (NASDAQ:AVAH) has a Due Diligence Score of 30, which is 5 points higher than the healthcare sector average of 25. It passed 10 out of 33 due diligence checks and has average fundamentals. Aveanna Healthcare Holdings has seen its stock return 74.31% over the past year, overperforming other healthcare stocks by 103 percentage points.

Aveanna Healthcare Holdings has an average 1 year price target of $8.08, a downside of -8.36% from Aveanna Healthcare Holdings's current stock price of $8.82.

Aveanna Healthcare Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Aveanna Healthcare Holdings, 33.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 70 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 13.94%, which is 12 percentage points higher than the healthcare sector average of 2.1%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 8.65%, which is 7 percentage points higher than the healthcare sector average of 2.1%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 7.97%, which is 6 percentage points higher than the healthcare sector average of 2.1%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 150.6% indicates that its high dividend yield might not be sustainable for the long-term.

Healthcare stocks were up 0.44% in the last day, and down -1.09% over the last week. Compugen was the among the top gainers in the healthcare sector, gaining 21.08% yesterday.

Compugen shares are trading higher after the company published pooled data showing COM701 activity in platinum-resistant ovarian cancer ahead of its ESMO presentation.

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -25.7% in the past year. It has overperformed other stocks in the healthcare sector by 3 percentage points.

Embecta (NASDAQ:EMBC) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has gained 1.99% in the past year. It has overperformed other stocks in the healthcare sector by 30 percentage points.

Auna Sa (NYSE:AUNA) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Auna Sa has a valuation score of 29, which is 13 points higher than the healthcare sector average of 16. It passed 2 out of 7 valuation due diligence checks.

Auna Sa's stock has dropped -5.48% in the past year. It has overperformed other stocks in the healthcare sector by 23 percentage points.

52.96% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 34.24% over the next year.

4.9% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.49% of healthcare stocks are rated B (Buy), 47.61% are rated C (Hold), 24.5% are rated D (Sell), and 10.5% are rated F (Strong Sell).